A Pilot Study Evaluating a Novel Biodynamic Imaging (BDI) Method in Predicating Response to Chemotherapy in Locoregional Esophageal Cancer

Study on Biodynamic Imaging Technique for Esophageal Cancer

Recruiting
18 years - 100 years
All
Phase N/A
1 Location

Brief description of study.

Researchers would like to determine if a new imaging technique called Biodynamic Imagining (BDI) is appropriate for clinical use in the treatment of esophageal cancer. The purpose of this study is to determine if the tumor tissue can be collected, transported and successfully processed using BDI technology.

Detailed description of study

Researchers would like to determine if a new imaging technique called Biodynamic Imagining (BDI) is appropriate for clinical use in the treatment of esophageal cancer. The purpose of this study is to determine if the tumor tissue can be collected, transported and successfully processed using BDI technology.

Participants will not be paid for their participation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: esophageal cancer
  • Age: 18 years - 100 years
  • Gender: All

Inclusion Criteria
Histologically confirmed adenocarcinoma of the esophagus
Must have a TNM stag I-III disease and no evidence of distant metastasis
Previously untreated for esophageal cancer
Must be medically fit and willing to receive chemoradiation therapy for their disease

Updated on 19 Feb 2024. Study ID: 1412977615 (IUCRO-0486)

This study investigates the use of a new imaging technique called Biodynamic Imaging (BDI) for esophageal cancer. The purpose of this study is to see if tumor tissue can be collected, transported, and processed using BDI technology. Esophageal cancer is a disease where malignant cells form in the tissues of the esophagus, which is the tube through which food passes from the throat to the stomach.

Participants in this study will have their tumor tissue collected and analyzed using the BDI technique. This process involves taking a sample of the tumor tissue to see if it can be successfully processed with BDI technology. The goal is to determine if this imaging method is suitable for clinical use.

  • Who can participate: Adults with a confirmed diagnosis of adenocarcinoma of the esophagus, at TNM stage I-III, and no distant metastasis may participate. Participants must be medically fit and willing to undergo chemoradiation therapy. They should not have received previous treatment for esophageal cancer.
  • Study details: Participants will have their tumor tissue analyzed using the Biodynamic Imaging (BDI) technique to evaluate the imaging method's effectiveness.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here